NCT01995396

Brief Summary

In patients with rectal cancer, an anterior resection with a colo-rectal or colo-anal anastomoses is the gold standard. However, in patients with a weak sphincter and fecal incontinence or in patients with severe co-morbidity and reduced general condition, this operation is not suitable. In these situations there are two other radical surgical options, Hartmanns procedure and the Abdominoperineal excision that can be performed with intersphincteric dissection to minimise perineal complications.There are no data on which of these procedures that are best suited for these patients with fecal incontinence or severe co-morbidity( at risk for life-threatening anastomotic leak). In this randomized study we intend to compare postoperative complications within 30 days after these two procedures and also late complications and quality of life after one year postoperatively.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
164

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 21, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 26, 2013

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2014

Completed
7.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

December 16, 2021

Status Verified

December 1, 2021

Enrollment Period

7.8 years

First QC Date

November 21, 2013

Last Update Submit

December 1, 2021

Conditions

Keywords

rectal cancer,fecal incontinence,severe co-morbidity,Hartmann´s procedure,abdominoperineal excision with intersphincteric dissection,postoperative complications,pelvic abscess,perineal infections

Outcome Measures

Primary Outcomes (1)

  • Rates ot postoperative surgical complications within 30 days.

    Perineal and abdominal wound infection, pelvic abscess urinary catheter at discharge etc

    30 days

Secondary Outcomes (7)

  • Peroperative data

    day of surgery

  • The rate of intraoperative perforations

    day of surgery

  • Resection margins

    2-4 weeks after surgery

  • Rate of local recurrence

    3 and 5 years postoperatively

  • Survival after 3 and 5 years follow-up

    3 and 5 years postoperativelly

  • +2 more secondary outcomes

Other Outcomes (2)

  • quality of life between the two methods

    Preoperative and one year after surgery

  • Late complications after surgery

    One year postoperativelly

Study Arms (2)

APE with intersphincteric dissection

ACTIVE COMPARATOR

Abdominoperineal excision with intersphincteric dissection and a stoma is performed in patients with rectal cancer and fecal incontinence and/or severe co-morbidity

Procedure: Hartmann´s procedure

Hartmann´s procedure

ACTIVE COMPARATOR

Hartmann´s operation and stoma is performed in patients with rectal cancer and fecal incontinence and/or severe co-morbidity

Procedure: APE with intersphincteric dissection

Interventions

Abdominal operation where the rectum is resected down to the levator and then the anus is resected by an intersphincteric dissection and order to leave the outer sfincter and levator in place to avoid a large wound and a high rate of infectious complications.

Hartmann´s procedure

Abdominal operation where the rectum is resected and stapled off distally and a stoma is created

APE with intersphincteric dissection

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Rectal cancer 5cm or more from the anal verge
  • Both procedures should be possible to perform
  • Patients should have co-morbidities and/or have weak anal sphincter where an anterior resection is not suitable
  • Metastases are no contraindication but the procedure should be assessed as locally radical.
  • Patients should be assesed to cope with a major abdominal procedure(ASA I-III)

You may not qualify if:

  • rectal cancer below 5cm from the anal verge where a Hartmann is considered not to be locally radical.
  • patients where an anterior resection is suitable
  • ASA IV or worse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Västmanlands Hospital Västerås

Västerås, 72189, Sweden

Location

Related Publications (2)

  • Nikberg M, Akerlund V, Swartling T, Buchwald P, Smedh K; HAPIrect Collaborative Study Group. Postoperative complications in Hartmann's procedure versus intersphincteric abdominoperineal excision in rectal cancer: randomized clinical trial (HAPIrect). BJS Open. 2025 Sep 8;9(5):zraf093. doi: 10.1093/bjsopen/zraf093.

  • Smedh K, Sverrisson I, Chabok A, Nikberg M; HAPIrect Collaborative Study Group. Hartmann's procedure vs abdominoperineal resection with intersphincteric dissection in patients with rectal cancer: a randomized multicentre trial (HAPIrect). BMC Surg. 2016 Jul 11;16(1):43. doi: 10.1186/s12893-016-0161-2.

MeSH Terms

Conditions

Rectal NeoplasmsFecal IncontinencePostoperative Complications

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Kenneth Smedh, PhD

    Region Vastmanland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 21, 2013

First Posted

November 26, 2013

Study Start

February 1, 2014

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

December 16, 2021

Record last verified: 2021-12

Locations